Skip to main content
. 2020 Nov 19;9(1):1844403. doi: 10.1080/2162402X.2020.1844403
CPS combined positive score
EMA European Medicine Agency
FDA Food and Drug Administration
HNSCC head and neck squamous cell carcinoma
NSCLC non–small cell lung cancer
OS overall survival
PD-1 programmed death-1
PD-L1 programmed death ligand 1
PFS progression-free survival
R/M recurrent/metastatic
TAM tumor-associated macrophage
TIL tumor-infiltrating lymphocyte
TPS tumor proportion score